全文获取类型
收费全文 | 4265篇 |
免费 | 327篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 109篇 |
妇产科学 | 85篇 |
基础医学 | 739篇 |
口腔科学 | 36篇 |
临床医学 | 383篇 |
内科学 | 858篇 |
皮肤病学 | 197篇 |
神经病学 | 216篇 |
特种医学 | 206篇 |
外国民族医学 | 2篇 |
外科学 | 928篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 238篇 |
眼科学 | 90篇 |
药学 | 293篇 |
中国医学 | 5篇 |
肿瘤学 | 186篇 |
出版年
2021年 | 48篇 |
2020年 | 40篇 |
2019年 | 50篇 |
2018年 | 68篇 |
2017年 | 41篇 |
2016年 | 72篇 |
2015年 | 94篇 |
2014年 | 79篇 |
2013年 | 158篇 |
2012年 | 224篇 |
2011年 | 246篇 |
2010年 | 142篇 |
2009年 | 159篇 |
2008年 | 214篇 |
2007年 | 237篇 |
2006年 | 226篇 |
2005年 | 206篇 |
2004年 | 163篇 |
2003年 | 182篇 |
2002年 | 154篇 |
2001年 | 114篇 |
2000年 | 118篇 |
1999年 | 109篇 |
1998年 | 60篇 |
1997年 | 43篇 |
1996年 | 38篇 |
1995年 | 31篇 |
1994年 | 27篇 |
1992年 | 74篇 |
1991年 | 58篇 |
1990年 | 75篇 |
1989年 | 50篇 |
1988年 | 43篇 |
1987年 | 51篇 |
1986年 | 49篇 |
1985年 | 63篇 |
1984年 | 38篇 |
1983年 | 32篇 |
1982年 | 27篇 |
1981年 | 29篇 |
1979年 | 37篇 |
1978年 | 33篇 |
1977年 | 34篇 |
1976年 | 35篇 |
1975年 | 29篇 |
1974年 | 27篇 |
1973年 | 35篇 |
1971年 | 34篇 |
1970年 | 28篇 |
1969年 | 30篇 |
排序方式: 共有4610条查询结果,搜索用时 15 毫秒
101.
Irene G. M. Van Valkengoed PhD Liffert Vogt MD PhD Bert‐Jan H. Van Den Born MD PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(2):122-126
The survival of patients with malignant hypertension (MHT) has considerably improved over the past decades. Data regarding the excess risk of mortality and the contribution of conventional cardiovascular risk factors are lacking. The authors retrospectively assessed cardiovascular risk factors and all‐cause mortality in 120 patients with a history of MHT and compared them with 120 normotensive and 120 hypertensive age‐, sex‐, and ethnicity‐matched controls. Total cholesterol, low‐density lipoprotein cholesterol, and body mass index were lower in MHT patients compared with hypertensive controls, whereas blood pressure, high‐density lipoprotein cholesterol, and smoking habit were similar. Median estimated glomerular filtration rate was lower in MHT patients compared with normotensive and hypertensive controls (both P<.01). The annual incidence of all‐cause mortality per 100 patient‐years was higher in MHT patients (2.6) compared with normotensive (0.2) and hypertensive (0.5) controls (both P<.01). Mortality of patients with a history of MHT remains high compared with normotensive and hypertensive controls. Patients with MHT had a more favorable cardiovascular risk profile compared with hypertensive controls but a higher prevalence of renal insufficiency. 相似文献
102.
Bjoern Moosmann Philippe Bisel Folker Westphal Maurice Wilde Jürgen Kempf Verena Angerer Volker Auwrter 《Drug testing and analysis》2019,11(3):541-549
The number of newly appearing benzodiazepine derivatives on the new psychoactive substances (NPS) drug market has increased over the last couple of years totaling 23 ‘designer benzodiazepines’ monitored at the end of 2017 by the European Monitoring Centre for Drugs and Drug Addiction. In the present study, three benzodiazepines [flunitrazolam, norflurazepam, and 4′‐chlorodiazepam (Ro5–4864)] offered as ‘research chemicals' on the Internet were characterized and their main in vitro phase I metabolites tentatively identified after incubation with pooled human liver microsomes. For all compounds, the structural formula declared by the vendor was confirmed by gas chromatography?mass spectrometry (GC–MS), liquid chromatography?tandem mass spectrometry (LC MS/MS), liquid chromatography?quadrupole time of flight?mass spectrometry (LC?QTOF?MS) analysis and nuclear magnetic resonance (NMR) spectroscopy. The metabolic steps of flunitrazolam were monohydroxylation, dihydroxylation, and reduction of the nitro function. The detected in vitro phase I metabolites of norflurazepam were hydroxynorflurazepam and dihydroxynorflurazepam. 4’‐Chlorodiazepam biotransformation consisted of N‐dealkylation and hydroxylation. It has to be noted that 4′‐chlorodiazepam and its metabolites show almost identical LC–MS/MS fragmentation patterns to diclazepam and its metabolites (delorazepam, lormetazepam, and lorazepam), making a sufficient chromatographic separation inevitable. Sale of norflurazepam, the metabolite of the prescribed benzodiazepines flurazepam and fludiazepam, presents the risk of incorrect interpretation of analytical findings. 相似文献
103.
104.
105.
106.
R Deogracias M Yazdani MP Dekkers J Guy MC Ionescu KE Vogt YA Barde 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(35):14230-14235
The functional relevance of brain-derived neurotrophic factor (BDNF) is beginning to be well appreciated not only in mice, but also in humans. Because reduced levels typically correlate with impaired neuronal function, increasing BDNF levels with well-tolerated drugs diffusing into the central nervous system may help in ameliorating functional deficits. With this objective in mind, we used the sphingosine-1 phosphate receptor agonist fingolimod, a drug that crosses the blood-brain barrier. In addition, fingolimod has recently been introduced as the first oral treatment for multiple sclerosis. In cultured neurons, fingolimod increases BDNF levels and counteracts NMDA-induced neuronal death in a BDNF-dependent manner. Ongoing synaptic activity and MAPK signaling is required for fingolimod-induced BDNF increase, a pathway that can also be activated in vivo by systemic fingolimod administration. Mice lacking Mecp2, a gene frequently mutated in Rett syndrome, show decreased levels of BDNF, and fingolimod administration was found to partially rescue these levels as well as the size of the striatum, a volumetric sensor of BDNF signaling in rodents. These changes correlate with increased locomotor activity of the Mecp2-deficient animals, suggesting that fingolimod may improve the functional output of the nervous system, in addition to its well-documented effects on lymphocyte egress from lymph nodes. 相似文献
107.
Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors 总被引:1,自引:0,他引:1
108.
B Sierra AB Pérez M Alvarez G García K Vogt E Aguirre K Schmolke HD Volk MG Guzmán 《The American journal of tropical medicine and hygiene》2012,87(3):538-547
Abstract. Secondary heterologous dengue infection is a risk factor for severe disease manifestations because of the immune-enhancement phenomenon. Succeeding clinical infections are seldom reported, and the clinical course of tertiary and quaternary dengue infections is not clear. Cuba represents a unique environment to study tertiary/quaternary dengue infections in a population with known clinical and serologic dengue markers and no dengue endemicity. We took advantage of this exceptional epidemiologic condition to study the effect of primary, secondary, tertiary, and quaternary dengue infection exposure on the expression of pro-inflammatory and regulatory cytokines, critical in dengue infection pathogenesis, by using a dengue infection ex vivo model. Whereas secondary exposure induced a high cytokine response, we found a significantly lower expression of tumor necrosis factor-α, interferon-γ, interleukin-10, and tumor growth factor-β after tertiary and quaternary infectious challenge. Significant differences in expression of the cytokines were seen between the dengue immune profiles, suggesting that the sequence in which the immune system encounters serotypes may be important in determining the nature of the immune response to subsequent infections. 相似文献
109.
B. A. Vogt 《Neurogastroenterology and motility》2013,25(2):93-98
The article by Agostini et al. (2013) in this issue of Neurogastroenterology and Motility evaluated patients with Crohn’s disease (CD) for volumetric changes throughout the brain. They observed decreased gray matter volumes in dorsolateral prefrontal cortex and anterior midcingulate cortex (aMCC) and disease duration was negatively correlated with volumes in subgenual anterior cingulate (sACC), posterior MCC (pMCC), ventral posterior cingulate (vPCC), and parahippocampal cortices. As all patients were in remission and suffered from ongoing abdominal pain, this study provides a critical link between forebrain changes and abdominal pain experience independent of active disease and drug treatment. The aMCC has a role in feedback‐mediated decision making and there are specific cognitive tasks that differentiate aMCC and pMCC that can be used to evaluate defects in CD. The sACC is an important area as it has impaired functions in major depression. As depressive symptoms are a feature in a subset of patients with active inflammatory diseases including IBD, treatment targeting this subregion should prove efficacious. Finally, vPCC has a role in ongoing self‐monitoring of the personal relevance of sensory stimuli including visceral signals via sACC. This pathway may be interrupted by vPCC atrophy in CD. Cingulate atrophy in CD leads to targeting chronic pain and psychiatric symptoms via cingulate‐mediated therapies. These include psychotherapy, guided imagery and relaxation training, analgesic dosages of morphine or antidepressants, and hypnosis. Thus, a new generation of novel treatments may emerge from drug and non‐traditional therapies for CD in this formative area of research. 相似文献
110.
Enck P Horing B Weimer K Klosterhalfen S 《European journal of gastroenterology & hepatology》2012,24(1):1-8
The nature and determinants of the placebo response are widely unknown, as are the underlying psychological and biological mechanisms. Placebo response rates in functional bowel disorders (functional dyspepsia, irritable bowel syndrome) trials are similar to those in nonintestinal pain conditions and are comparable with other organic gastrointestinal diseases (duodenal ulcer, inflammatory bowel diseases). In this narrative review, different methodologies (meta-analyses, reanalyses, and experimental setups) are discussed that have been applied to the study of the placebo response in functional dyspepsia and the irritable bowel syndrome. 相似文献